Xagenic Seals $10M Series A

Xagenic Inc., a molecular diagnostics company spun out of the University of Toronto, has raised $10 million in Series A financing co-led by CTI Life Sciences Fund and the Ontario Emerging Technologies Fund. QIAGEN N.V. also participated in the round. Toronto-based Xagenic will use the funds to continue development of its technology for decentralized, rapid diagnostic testing.

North AmericaUSBriefs